SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$8.41M-9.8% | -$7.66M-12.8% | -$6.79M-2.9% | -$6.6M-13.6% | -$5.81M+13.7% | ||
| $798K+78.5% | $447K-11.1% | $503K+0.4% | $501K-0.8% | $505K+35.4% | ||
| -$8.85M-79.8% | -$4.92M+30.4% | -$7.07M+3.6% | -$7.33M+19.2% | -$9.07M-26.8% | ||
| $44.15M+36.3% | $32.39M+24.2% | $26.09M+517% | $4.23M-82.1% | $23.58M+294,663% | ||
| $35.3M+28.5% | $27.47M+44.4% | $19.02M— | $0-100% | $14.51M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does SELLAS Life Sciences Group, Inc. generate?
- SELLAS Life Sciences Group, Inc. (SLS) generated -$28.2M in operating cash flow over the trailing twelve months.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.